Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Treasury Shares (2023 - 2025)

Historic Treasury Shares for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $525350.0.

  • Zenas BioPharma's Treasury Shares changed N/A to $525350.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $525350.0, marking a year-over-year change of. This contributed to the annual value of $21172.0 for FY2024, which is 2216.18% down from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's Treasury Shares is $525350.0.
  • Zenas BioPharma's Treasury Shares' 5-year high stood at $525350.0 during Q3 2025, with a 5-year trough of $21172.0 in Q1 2024.
  • For the 3-year period, Zenas BioPharma's Treasury Shares averaged around $221198.8, with its median value being $27200.0 (2023).
  • Examining YoY changes over the last 5 years, Zenas BioPharma's Treasury Shares showed a top increase of 2216.18% in 2024 and a maximum decrease of 2216.18% in 2024.
  • Quarter analysis of 3 years shows Zenas BioPharma's Treasury Shares stood at $27200.0 in 2023, then fell by 22.16% to $21172.0 in 2024, then surged by 2381.34% to $525350.0 in 2025.
  • Its last three reported values are $525350.0 in Q3 2025, $511100.0 for Q2 2025, and $21172.0 during Q4 2024.